Alison Bauerlein, EVP, Finance, & CFO at Inogen, holds 426.25K shares in Sight Sciences (Ticker: SGHT), holds 71.43K shares in Pear Therapeutics (Ticker: PEARQ), holds 51.09K shares in Gelesis Holdings (Ticker: GLSHQ). Most recently, Alison Bauerlein Sold ― shares of Sight Sciences on Apr 04, 2024 for an estimated value of 51.32K.